Diagnosis and treatment of pulmonary hypertension : from bench to bedside
Author(s)
Bibliographic Information
Diagnosis and treatment of pulmonary hypertension : from bench to bedside
Springer Nature, c2017
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references
Description and Table of Contents
Description
This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
Table of Contents
Part I Fundamentals of Pulmonary Hypertension.- 1.Clinical Classification.- 2.Diagnosis - Imagings.- Part II Pathophysiology and Genetics.- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension.- 4.Sex Hormones.- 5.Rho-Kinase.- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension.- 7. Animal Models with Pulmonary Hypertension.- 8.Human Pathology.- 9. Pathophysiology and Genetics: BMPR2.- Part III Treatment of Pulmonary Arterial Hypertension (PAH).- 10. Prostacyclin.- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension.- 12. Endothelin Receptor Antagonist.- 13. LUNG TRANSPLANTATION.- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension.- 15. Balloon Pulmonary Angioplasty.- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.- Part V Right Ventricular Function.- 17. Right Ventricular Function.
by "Nielsen BookData"